The Role of Vitamin D in SARS-CoV-2 Infection and Acute Kidney Injury
Open Access
- 1 July 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (13) , 7368
Abstract
Vitamin D has been described as an essential nutrient and hormone, which can cause nuclear, non-genomic, and mitochondrial effects. Vitamin D not only controls the transcription of thousands of genes, directly or indirectly through the modulation of calcium fluxes, but it also influences the cell metabolism and maintenance specific nuclear programs. Given its broad spectrum of activity and multiple molecular targets, a deficiency of vitamin D can be involved in many pathologies. Vitamin D deficiency also influences mortality and multiple outcomes in chronic kidney disease (CKD). Active and native vitamin D serum levels are also decreased in critically ill patients and are associated with acute kidney injury (AKI) and in-hospital mortality. In addition to regulating calcium and phosphate homeostasis, vitamin D-related mechanisms regulate adaptive and innate immunity. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have a role in excessive proinflammatory cell recruitment and cytokine release, which contribute to alveolar and full-body endothelial damage. AKI is one of the most common extrapulmonary manifestations of severe coronavirus disease 2019 (COVID-19). There are also some correlations between the vitamin D level and COVID-19 severity via several pathways. Proper vitamin D supplementation may be an attractive therapeutic strategy for AKI and has the benefits of low cost and low risk of toxicity and side effects.Keywords
Funding Information
- Taoyuan Armed Forces General Hospital (TYAFGH-D-111038)
This publication has 123 references indexed in Scilit:
- Is the Serum Vitamin D Level at the Time of Hospital-Acquired Acute Kidney Injury Diagnosis Associated with Prognosis?PLOS ONE, 2013
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill*Critical Care Medicine, 2011
- Lineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T CellsJournal of Biological Chemistry, 2011
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increaseProceedings of the National Academy of Sciences, 2008
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General PopulationArchives of internal medicine (1960), 2008
- Does FGF23 toxicity influence the outcome of chronic kidney disease?Nephrology Dialysis Transplantation, 2008
- Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levelsDiabetic Medicine, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007